Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes

医学 ARID1A型 危险系数 肿瘤科 内科学 外显子组测序 比例危险模型 突变 基因 遗传学 生物 置信区间
作者
Daniel Noerenberg,Franziska Briest,Cornelius Hennch,Kenichi Yoshida,Raphael Hablesreiter,Yasuhide Takeuchi,Hiroo Ueno,Annette M. Staiger,Marita Ziepert,Fazila Asmar,Benjamin Nick Locher,Erika Tóth,Thomas E. Weber,Rose‐Marie Amini,Wolfram Klapper,Maria Bouzani,Viola Poeschel,Andreas Rosenwald,Gerhard Held,Elı́as Campo
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:42 (4): 452-466 被引量:41
标识
DOI:10.1200/jco.23.01053
摘要

PURPOSE Primary mediastinal large B-cell lymphoma (PMBCL) is a rare aggressive lymphoma predominantly affecting young female patients. Large-scale genomic investigations and genetic markers for risk stratification are lacking. PATIENTS AND METHODS To elucidate the full spectrum of genomic alterations, samples from 340 patients with previously untreated PMBCL were investigated by whole-genome (n = 20), whole-exome (n = 78), and targeted (n = 308) sequencing. Statistically significant prognostic variables were identified using a multivariable Cox regression model and confirmed by L1/L2 regularized regressions. RESULTS Whole-genome sequencing revealed a commonly disrupted p53 pathway with nonredundant somatic structural variations (SVs) in TP53-related genes ( TP63, TP73, and WWOX) and identified novel SVs facilitating immune evasion ( DOCK8 and CD83). Integration of mutation and copy-number data expanded the repertoire of known PMBCL alterations (eg, ARID1A, P2RY8, and PLXNC1) with a previously unrecognized role for epigenetic/chromatin modifiers. Multivariable analysis identified six genetic lesions with significant prognostic impact. CD58 mutations (31%) showed the strongest association with worse PFS (hazard ratio [HR], 2.52 [95% CI, 1.50 to 4.21]; P < .001) and overall survival (HR, 2.33 [95% CI, 1.14 to 4.76]; P = .02). IPI high-risk patients with mutated CD58 demonstrated a particularly poor prognosis, with 5-year PFS and OS rates of 41% and 58%, respectively. The adverse prognostic significance of the CD58 mutation status was predominantly observed in patients treated with nonintensified regimens, indicating that dose intensification may, to some extent, mitigate the impact of this high-risk marker. By contrast, DUSP2-mutated patients (24%) displayed durable responses (PFS: HR, 0.2 [95% CI, 0.07 to 0.55]; P = .002) and prolonged OS (HR, 0.11 [95% CI, 0.01 to 0.78]; P = .028). Upon CHOP-like treatment, these patients had very favorable outcome, with 5-year PFS and OS rates of 93% and 98%, respectively. CONCLUSION This large-scale genomic characterization of PMBCL identified novel treatment targets and genetic lesions for refined risk stratification. DUSP2 and CD58 mutation analyses may guide treatment decisions between rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone and dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
缓慢藏鸟发布了新的文献求助10
刚刚
GD完成签到,获得积分10
1秒前
1秒前
nn完成签到,获得积分10
1秒前
Menand发布了新的文献求助10
2秒前
完美世界的应助被ClaudiaCY采纳,获得10
2秒前
2秒前
羊粑粑的应助被零零零采纳,获得10
2秒前
慕青的应助被魔术师采纳,获得10
3秒前
3秒前
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
4秒前
qsyr2015完成签到,获得积分10
4秒前
shuiyu完成签到,获得积分10
5秒前
李爱国的应助被哈桑的过程采纳,获得10
5秒前
火星仙人掌完成签到 ,获得积分10
5秒前
5秒前
6秒前
重重完成签到 ,获得积分10
6秒前
哦莫发布了新的文献求助10
6秒前
爱在深秋完成签到,获得积分10
7秒前
杨山坡完成签到 ,获得积分10
7秒前
暖柚发布了新的文献求助10
8秒前
maxiaole的应助被fortuna采纳,获得10
8秒前
8秒前
Samuel发布了新的文献求助10
9秒前
顺心妙之完成签到 ,获得积分10
10秒前
10秒前
10秒前
Penny完成签到,获得积分10
10秒前
无极微光的应助被彩色蚂蚁采纳,获得20
10秒前
NNKK发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817